S&P 500 Gains and Losses Today: Eli Lilly Stock Falls as Sales Outlook Weakens
1. Eli Lilly cut its full-year revenue outlook significantly. 2. Healthy demand for Mounjaro and Zepbound may not be met. 3. Eli Lilly shares dropped 6.6%, the largest decline in S&P 500. 4. The company invests heavily in manufacturing capacity expansion. 5. Market reaction indicates serious concerns about future sales.